Please login to the form below

Not currently logged in
Email:
Password:

Zeltiq Aesthetics

This page shows the latest Zeltiq Aesthetics news and features for those working in and with pharma, biotech and healthcare.

Allergan adds Zeltiq to M&A roster in $2.48n deal

Allergan adds Zeltiq to M&A roster in $2.48n deal

Expands aesthetic pharma business with “best-in-class” body contouring system. Botox manufacturer Allergan has bolstered its cosmetic product portfolio once again, signing a $2.48bn agreement to buy Zeltiq Aesthetics. ... The Zeltiq acquisition marks

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    Following its spate of deals last year, Allergan is paying $2.48bn ($56.50 per share, a 14.4% premium) to acquire ZELTIQ Aesthetics to enhance its global medical aesthetics portfolio. ... Royalty monetisation. 2, 850. ZELTIQ Aesthetics/ Allergan.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Genoscience Pharma expands board of directors Genoscience Pharma expands board of directors

    He most recently served as Pharmcyclics' chief financial officer and treasurer and has also held management positions at ZELTIQ Aesthetics and PriceWaterhouseCoopers, where he worked in PwC's San Jose office

  • Versartis names chief financial officer Versartis names chief financial officer

    He already has life sciences financial experience, having previously served as chief financial officer for Zeltiq Aesthetics and director of finance at Proteolix.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics